Register for your FREE account now and join thousands of oncology professionals who stay informed about patient care issues, practical oncology-care management techniques, and drug administration and dosage information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Chemotherapy

Modified stem cells keep glioblastoma at bay

Delicia Honen Yard May 25, 2012

Three patients with glioblastoma lived longer than predicted after receiving transplants of their own blood stem cells that had been gene-modified.
 

Imaging predicts breast cancer response to chemotherapy

May 24, 2012

Magnetic resonance imaging is better than clinical assessment for women undergoing pre-op chemo.
 

Infusing paclitaxel without an inline filter

May 22, 2012

What are the potential problems associated with infusing paclitaxel without an inline filter?
 

SPECT/CT guides postop management of thyroid cancer

Delicia Honen Yard May 21, 2012

Information from SPECT/ CT scans helps determine the need for radioiodine therapy in persons with thyroid cancer and influences follow-up strategy.
 

ASCO: Oncologists better ID long-term effects of chemo

May 21, 2012

Very few primary care physicians identified main late or long-term effects of four chemo drugs.
 

ASCO: For chemo's nausea, olanzapine beats metoclopramide

May 17, 2012

Patients with breakthrough chemo-induced nausea and vomiting benefit from olanzapine.
 

More chemotherapy might be best move for some children with leukemia

Delicia Honen Yard May 15, 2012

When induction therapy fails in acute lymphoblastic leukemia, some youths have better outcomes with more chemotherapy than with stem cell transplant.
 

Potentially treatable side effects plague breast cancer survivors for years

Delicia Honen Yard May 11, 2012

Six years after breast cancer treatment, more than 60% of women experienced at least one side effect amenable to rehabilitative intervention.
 

Fewer cycles of higher-dose chemotherapy best in advanced Hodgkin lymphoma

Delicia Honen Yard May 10, 2012

Six cycles of higher-dose chemotherapy, not the standard eight cycles or a lower-dose variant, should be the treatment of choice for advanced Hodgkin.
 

MediPort nurse program increases patient satisfaction

May 04, 2012

Drawing blood and administering chemotherapy using a MediPort device eliminates the number of needle sticks and increases patient satisfaction.
 

Telehealth network can be used to certify nurses in chemotherapy biotherapy

May 04, 2012

Nurses living in rural areas can become certified using a telehealth network.
 

Nurses play critical role in preventing DPD complications

May 03, 2012

Oncology nurses should focus on anticipating and managing risks for toxicity caused by dihydropyrimidine dehydrogenase enzyme deficiency.
 

Educational DVD about chemotherapy assuages patient fears about treatment

May 03, 2012

Used as an education tool prior to therapy, patients felt more in control, experienced less anxiety, and set realistic expectations.
 

PET response signals increased survival in soft-tissue sarcoma

Delicia Honen Yard May 02, 2012

Patients with soft-tissue sarcoma who have an early PET response after initial chemotherapy survive longer than patients showing no such response.
 

A second gene may predispose women to breast cancer

April 30, 2012

Scientists have discovered that the Abraxas gene may advance the mission of BRCA1 and may even act on its own to help breast cancer develop.
 

Votrient approved to treat advanced soft tissue sarcoma

April 30, 2012

Drug inhibits process that fuels tumor growth.
 

No benefit of induction chemo, high-dose boost in anal cancer

April 27, 2012

Colostomy-free survival not improved in patients with locally advanced anal canal carcinoma.
 

No link between BMI and surgical outcome in esophageal cancer

Delicia Honen Yard April 25, 2012

BMI appears to have no bearing on surgical complications or survival after esophagectomy following neoadjuvant chemoradiotherapy for adenocarcinoma.
 

New marker flags DNA repair response to platinum therapy

Delicia Honen Yard April 24, 2012

A new marker of DNA damage may predict which triple-negative breast cancers or serous ovarian cancers will respond to platinum-based chemotherapy.
 

Managing side effects of crizotinib

April 18, 2012

What specific visual changes are associated with the new drug crizotinib and what causes them?
 

Nutrition, mobility predict early death in elderly cancer patients

April 18, 2012

Low nutritional test score, poor mobility, and advanced disease predict early death after chemotherapy initiation.
 

VEGF blockade: Optimizing chemotherapy drug uptake

April 17, 2012

New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.
 

Genetic profile IDs leukemia patients for high-dose chemotherapy

Delicia Honen Yard April 17, 2012

Persons with acute myeloid leukemia who harbor specific gene mutations may have improved overall survival with higher doses of chemotherapy.
 

Leukemia: Understanding its types and treatments

April 13, 2012

This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.
 

Many women with cancer missing fertility risk info, services

Delicia Honen Yard April 11, 2012

Few women of childbearing age who are diagnosed with cancer are taking steps to preserve their fertility during treatment.
 

Perceived stigma drives depression in lung cancer

Delicia Honen Yard April 09, 2012

Greater levels of perceived stigma were related to greater levels of depression in a recent study of persons with non-small cell lung cancer.
 

Asian breast cancer patients unaware of "chemobrain"

April 04, 2012

The cognitive effects of chemotherapy are unfamiliar to Asian breast cancer patients even though these disturbances have affected their daily lives.
 

Cetuximab with chemo doesn't improve colon cancer outcome

April 04, 2012

For stage III resected colon cancer, disease-free survival is no better than with mFOLFOX6 alone.
 

Prophylaxis with apixaban feasible for cancer patients

April 01, 2012

Phase II study shows Factor Xa inhibitor is safe and tolerated in chemotherapy-treated patients.
 

Chemo-linked factors may impact weight in breast cancer

March 31, 2012

Early breast cancer chemotherapy-induced weight gain and metabolic changes may affect prognosis.
 

Web Exclusives

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Lenalidomide use after autologous stem-cell transplant significantly improved progression-free and overall survival in patients with myeloma.
 

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.
 

Modified stem cells keep glioblastoma at bay

Delicia Honen Yard May 25, 2012

Three patients with glioblastoma lived longer than predicted after receiving transplants of their own blood stem cells that had been gene-modified.
 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions